Pfizer antes up on the feds' vaccine criticism, saying Warp Speed has everything it's asked for—and more

U.S. officials took aim at Pfizer’s COVID-19 vaccine manufacturing process at a press conference Wednesday, suggesting the drugmaker had, at last, divulged production hiccups that could scupper efforts to get millions of shots into patients’ arms by year-end. But Pfizer sees things very differently—and it made those thoughts clear in a Thursday statement. “Pfizer is not having any production issues with our COVID-19 vaccine, and no shipments containing the vaccine are on hold or delayed,' the drugmaker said. In fact, it said, millions of doses are sitting in warehouses, ready for shipment whenever the government calls for them. And Pfizer board member and ex-FDA chief Scott Gottlieb, M.D., pitched his take Friday morning, speculating the government may have “throttled” Pfizer’s orders to make way for a looming Moderna rollout.